kynurenic acid has been researched along with ketamine in 31 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (22.58) | 18.7374 |
| 1990's | 16 (51.61) | 18.2507 |
| 2000's | 1 (3.23) | 29.6817 |
| 2010's | 5 (16.13) | 24.3611 |
| 2020's | 2 (6.45) | 2.80 |
| Authors | Studies |
|---|---|
| Dubner, R; Hylden, JL; Ren, K; Ruda, MA; Williams, GM | 1 |
| Ivanova, SF; Sanzharovskiĭ, AV; Storozhuk, VM | 1 |
| Barun, S; Dalkara, T; Erdemli, G; Onur, R | 1 |
| Wayman, CP; Wilson, JF | 1 |
| Ma, T; Tseng, MT; Zhou, M | 1 |
| Lipton, P; Lobner, D | 1 |
| Keilhoff, G; Schmidt, W; Stastný, F; Wolf, G | 1 |
| Baimbridge, KG; Kessler, M; Lynch, G; Oliver, MW; Shacklock, JA | 1 |
| Herberg, LJ; Rose, IC | 1 |
| Davidoff, RA; Hackman, JC; Zhang, DX | 1 |
| MacDonald, JF; Schneiderman, JH | 1 |
| Goto, Y; Ishida, M; Shinozaki, H | 1 |
| Hilakivi, I; Loikas, P | 1 |
| Davies, SN; Lodge, D | 1 |
| Mayer, ML; Vyklický, L; Westbrook, GL | 1 |
| Song, XJ; Zhao, ZQ | 2 |
| Henry, JL; Radhakrishnan, V | 1 |
| D'Hooge, R; De Deyn, PP; Pei, YQ | 1 |
| Bousquet, P; Feldman, J; Mettauer, B; Monassier, L; Roegel, JC; Tibiriça, E | 1 |
| Brainard, MS; Feldman, DE; Knudsen, EI | 1 |
| Bousquet, P; Chapleau, D; Crambes, A; Feldman, J; Monassier, L; Roegel, JC | 1 |
| Mazarati, AM; Wasterlain, CG | 1 |
| Geiger, JD; Hochman, S; Moore, A; Nath, A; Song, L | 1 |
| Benedek, G; Farkas, I; Horvath, G; Joo, G; Kekesi, G; Petrovszki, Z; Tuboly, G | 1 |
| Arora, S; Kaur, T; Pundir, M; Singh, AP; Singh, R | 1 |
| Chen, L; Li, H; Li, M; Liu, W; Ning, Y; Wang, C; Zhan, Y; Zheng, W; Zhou, Y | 1 |
| Harkin, A; McLoughlin, DM | 1 |
| Abdel-Ahad, P; Blatzer, M; Callebert, J; Chrétien, F; Danckaert, A; de Maricourt, P; De Medeiros, GF; Gaillard, R; Jouvion, G; Langeron, O; Launay, JM; Maignan, A; Petit, AC; Sharshar, T; Van Steenwinckel, J; Verdonk, F; Vinckier, F | 1 |
| Fan, N; Lu, H; Luo, Y; Ni, X; Wen, Y; Zhang, M; Zhang, Z | 1 |
| Courtet, P; Lengvenyte, A; Olié, E | 1 |
31 other study(ies) available for kynurenic acid and ketamine
| Article | Year |
|---|---|
The intrathecal administration of excitatory amino acid receptor antagonists selectively attenuated carrageenan-induced behavioral hyperalgesia in rats.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Analgesics; Analysis of Variance; Animals; Behavior, Animal; Carrageenan; Dizocilpine Maleate; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, D-Penicillamine (2,5)-; Enkephalins; Hyperalgesia; Inflammation; Injections, Spinal; Ketamine; Kynurenic Acid; Male; Piperazines; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Valine | 1992 |
[Role of glutamate intracortical connections in conditioned reflex activity].
Topics: 2-Amino-5-phosphonovalerate; Animals; Cats; Cerebral Cortex; Conditioning, Classical; Evoked Potentials, Somatosensory; Glutamates; Glutamic Acid; Iontophoresis; Ketamine; Kynurenic Acid; Membrane Potentials; Neurons; Receptors, N-Methyl-D-Aspartate | 1992 |
Glycine is required for NMDA receptor activation: electrophysiological evidence from intact rat hippocampus.
Topics: Animals; Dizocilpine Maleate; Electric Stimulation; Electrophysiology; Evoked Potentials; Glycine; Hippocampus; Iontophoresis; Ketamine; Kynurenic Acid; Magnesium; Male; N-Methylaspartate; Rats; Receptors, N-Methyl-D-Aspartate; Time Factors | 1992 |
Characteristics of NMDA receptors that stimulate release of hypothalamic alpha-MSH.
Topics: alpha-MSH; Animals; Hypothalamus; In Vitro Techniques; Ketamine; Kinetics; Kynurenic Acid; Magnesium; Male; N-Methylaspartate; Rats; Rats, Inbred Strains; Receptors, N-Methyl-D-Aspartate; Serine | 1991 |
Effects of taurine and ketamine on bovine retinal membrane lipid peroxidation.
Topics: Animals; Ascorbic Acid; Cadmium; Cadmium Chloride; Calcium; Cattle; Dextromethorphan; Female; Ischemia; Ketamine; Kynurenic Acid; Lipid Peroxidation; Membrane Lipids; Receptors, N-Methyl-D-Aspartate; Reperfusion Injury; Retina; Taurine; Trifluoperazine | 1991 |
Sigma-ligands and non-competitive NMDA antagonists inhibit glutamate release during cerebral ischemia.
Topics: 2-Amino-5-phosphonovalerate; Amino Acids; Animals; Anticonvulsants; Cyclazocine; Dizocilpine Maleate; Glutamates; Guanidines; Haloperidol; Hippocampus; In Vitro Techniques; Ischemic Attack, Transient; Ketamine; Kynurenic Acid; Male; Models, Neurological; Phencyclidine; Pyramidal Tracts; Rats; Rats, Inbred Strains; Receptors, N-Methyl-D-Aspartate; Receptors, Opioid; Receptors, sigma | 1990 |
Quinolinate neurotoxicity and glutamatergic structures.
Topics: Age Factors; Animals; Dose-Response Relationship, Drug; Glutamates; Glutamic Acid; Hippocampus; Injections, Intraventricular; Ketamine; Kynurenic Acid; Male; Neurotoxins; Pyridines; Quinolinic Acid; Quinolinic Acids; Rats; Rats, Inbred Strains | 1990 |
The glycine site modulates NMDA-mediated changes of intracellular free calcium in cultures of hippocampal neurons.
Topics: 2-Amino-5-phosphonovalerate; Animals; Aspartic Acid; Calcium; Cells, Cultured; Embryo, Mammalian; Glycine; Hippocampus; Ketamine; Kinetics; Kynurenic Acid; Macromolecular Substances; N-Methylaspartate; Neurons; Rats; Receptors, Glycine; Receptors, N-Methyl-D-Aspartate; Receptors, Neurotransmitter; Serine | 1990 |
The effect of MK-801 and other antagonists of NMDA-type glutamate receptors on brain-stimulation reward.
Topics: Animals; Anticonvulsants; Aspartic Acid; Brain; Dibenzocycloheptenes; Dizocilpine Maleate; Dose-Response Relationship, Drug; Ketamine; Kynurenic Acid; Male; N-Methylaspartate; Rats; Receptors, Glutamate; Receptors, Neurotransmitter; Self Stimulation | 1989 |
NMDA antagonists and potentiation of NMDA-induced motoneuron depolarizations in the isolated frog spinal cord.
Topics: 2-Amino-5-phosphonovalerate; Amino Acids; Animals; Aspartic Acid; Cell Membrane; Dibenzocycloheptenes; Dizocilpine Maleate; Drug Synergism; Evoked Potentials; Ketamine; Kynurenic Acid; Magnesium; Motor Neurons; N-Methylaspartate; Potassium; Rana pipiens; Spinal Cord; Valine | 1989 |
Excitatory amino acid blockers differentially affect bursting of in vitro hippocampal neurons in two pharmacological models of epilepsy.
Topics: 2-Amino-5-phosphonovalerate; Action Potentials; Animals; Epilepsy; Guinea Pigs; Hippocampus; In Vitro Techniques; Ketamine; Kynurenic Acid; Phencyclidine; Receptors, Amino Acid; Receptors, Cell Surface | 1989 |
Depression of decerebrate rigidity in the rat by antagonists of excitatory amino acids.
Topics: Amino Acids; Animals; Anticonvulsants; Azepines; Blood Pressure; Decerebrate State; Dibenzocycloheptenes; Dizocilpine Maleate; Ketamine; Kynurenic Acid; Male; Muscle Relaxants, Central; Muscle Rigidity; Oxazoles; Oxazolidinones; Piperazines; Rats; Rats, Inbred Strains | 1989 |
Effects of kynurenic acid and ketamine on neonatal sleep in rats.
Topics: Animals; Animals, Newborn; Behavior, Animal; Female; Ketamine; Kynurenic Acid; Rats; Sleep | 1989 |
Evidence for involvement of N-methylaspartate receptors in 'wind-up' of class 2 neurones in the dorsal horn of the rat.
Topics: Animals; Electric Stimulation; Injections, Intravenous; Iontophoresis; Ketamine; Kynurenic Acid; Neurons; Rats; Receptors, N-Methyl-D-Aspartate; Receptors, Neurotransmitter; Spinal Cord | 1987 |
Sites of antagonist action on N-methyl-D-aspartic acid receptors studied using fluctuation analysis and a rapid perfusion technique.
Topics: 2-Amino-5-phosphonovalerate; Animals; Aspartic Acid; Binding Sites; Binding, Competitive; Cations, Divalent; Cells, Cultured; Glycine; Hippocampus; Ketamine; Kynurenic Acid; Magnesium; Mice; Mice, Inbred C57BL; N-Methylaspartate; Receptors, N-Methyl-D-Aspartate; Receptors, Neurotransmitter; Valine; Zinc | 1988 |
Interaction between substance P and excitatory amino acid receptors in modulation of nociceptive responses of cat spinal dorsal horn neurons.
Topics: 2-Amino-5-phosphonovalerate; Animals; Cats; Electric Stimulation; Homocysteine; Ketamine; Kynurenic Acid; Muscles; Neurokinin-1 Receptor Antagonists; Neurons; Nociceptors; Quinoxalines; Receptors, Glutamate; Receptors, N-Methyl-D-Aspartate; Receptors, Neurokinin-1; Spinal Cord; Substance P; Sural Nerve | 1994 |
Excitatory amino acid receptor mediation of sensory inputs to functionally identified dorsal horn neurons in cat spinal cord.
Topics: 2-Amino-5-phosphonovalerate; 6-Cyano-7-nitroquinoxaline-2,3-dione; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Cats; Decerebrate State; Evoked Potentials; Glutamates; Glutamic Acid; Ibotenic Acid; Kainic Acid; Ketamine; Kynurenic Acid; N-Methylaspartate; Neurons; Quinoxalines; Quisqualic Acid; Receptors, Amino Acid; Receptors, N-Methyl-D-Aspartate; Spinal Cord; Synapses | 1993 |
N-methyl-D-aspartate receptors contribute to guanidinosuccinate-induced convulsions in mice.
Topics: 2-Amino-5-phosphonovalerate; Animals; Anticonvulsants; Drug Interactions; Female; Glutamates; Glutamic Acid; Guanidines; Kainic Acid; Ketamine; Kynurenic Acid; Male; Mice; Receptors, N-Methyl-D-Aspartate; Seizures; Succinates | 1993 |
Prevention by NMDA receptor antagonists of the centrally-evoked increases of cardiac inotropic responses in rabbits.
Topics: 2-Amino-5-phosphonovalerate; Animals; Blood Pressure; Electric Stimulation; Glutamates; Glutamic Acid; Ketamine; Kynurenic Acid; Male; Myocardial Contraction; Paraventricular Hypothalamic Nucleus; Rabbits; Receptors, N-Methyl-D-Aspartate | 1994 |
Differential effects of NMDA and non-NMDA receptor antagonists on spinal cutaneous vs muscular nociception in the cat.
Topics: 2-Amino-5-phosphonovalerate; Animals; Cats; Iontophoresis; Ketamine; Kynurenic Acid; Muscles; Nerve Fibers; Nociceptors; Receptors, Amino Acid; Receptors, N-Methyl-D-Aspartate; Skin Physiological Phenomena; Spinal Cord; Synaptic Transmission | 1993 |
Newly learned auditory responses mediated by NMDA receptors in the owl inferior colliculus.
Topics: 2-Amino-5-phosphonovalerate; 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Auditory Perception; Birds; Diazepam; Excitatory Amino Acid Antagonists; Inferior Colliculi; Ketamine; Kynurenic Acid; Learning; Neuronal Plasticity; Receptors, N-Methyl-D-Aspartate; Sound Localization; Synaptic Transmission; Visual Perception | 1996 |
GABAergic and glutaminergic modulation of centrally evoked arrhythmias in rats.
Topics: Animals; Arrhythmias, Cardiac; Baclofen; Brain; Cardiovascular System; Electric Stimulation; GABA Agonists; gamma-Aminobutyric Acid; Glutamine; Injections, Intravenous; Injections, Intraventricular; Ketamine; Kynurenic Acid; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Sympathetic Nervous System; Synaptic Transmission | 1996 |
N-methyl-D-asparate receptor antagonists abolish the maintenance phase of self-sustaining status epilepticus in rat.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Action Potentials; Animals; Anticonvulsants; Disease Models, Animal; Dizocilpine Maleate; Electric Stimulation; Excitatory Amino Acid Antagonists; Hippocampus; Ketamine; Kynurenic Acid; Male; Perforant Pathway; Rats; Rats, Wistar; Receptors, AMPA; Receptors, Kainic Acid; Receptors, N-Methyl-D-Aspartate; Status Epilepticus | 1999 |
Human immunodeficiency virus type 1 Tat protein directly activates neuronal N-methyl-D-aspartate receptors at an allosteric zinc-sensitive site.
Topics: 2-Amino-5-phosphonovalerate; Action Potentials; Allosteric Regulation; Allosteric Site; Animals; Excitatory Amino Acid Antagonists; Gene Products, tat; Hippocampus; HIV-1; Humans; Ketamine; Kynurenic Acid; Neurons; Patch-Clamp Techniques; Protein Interaction Mapping; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; tat Gene Products, Human Immunodeficiency Virus; Zinc | 2003 |
Inhibition of itch-related responses at spinal level in rats.
Topics: 5-Methoxytryptamine; Analgesics; Animals; Behavior, Animal; Disease Models, Animal; Drug Interactions; Excitatory Amino Acid Antagonists; Injections, Spinal; Ketamine; Kynurenic Acid; Male; Naltrexone; Narcotic Antagonists; Pruritus; Rats; Rats, Wistar; Spinal Cord | 2011 |
Effect of modulating the allosteric sites of N-methyl-D-aspartate receptors in ischemia-reperfusion induced acute kidney injury.
Topics: Acute Kidney Injury; Allosteric Site; Animals; Catalase; Glutamic Acid; Glutathione; Ketamine; Kynurenic Acid; Magnesium Sulfate; Male; Models, Animal; Oxidative Stress; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Reperfusion Injury; Spermidine; Superoxides; Thiobarbituric Acid Reactive Substances | 2013 |
Antidepressant effect of repeated ketamine administration on kynurenine pathway metabolites in patients with unipolar and bipolar depression.
Topics: Administration, Intravenous; Adult; Antidepressive Agents; Bipolar Disorder; China; Chromatography, Liquid; Depression; Depressive Disorder; Female; Humans; Ketamine; Kynurenic Acid; Kynurenine; Male; Tandem Mass Spectrometry; Tryptophan | 2018 |
Ketamine and depression: A special kase for kynurenic acid?
Topics: Animals; Antidepressive Agents; Depression; Depressive Disorder; Humans; Ketamine; Kynurenic Acid; Kynurenine | 2019 |
Microglial production of quinolinic acid as a target and a biomarker of the antidepressant effect of ketamine.
Topics: Animals; Antidepressive Agents; Anxiety; Anxiety Disorders; Biomarkers, Pharmacological; Depression; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Disease Models, Animal; Inflammation; Ketamine; Kynurenic Acid; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Microglia; Quinolinic Acid | 2019 |
Preliminary comparative analysis of kynurenine pathway metabolites in chronic ketamine users, schizophrenic patients, and healthy controls.
Topics: Adult; Case-Control Studies; Chromatography, High Pressure Liquid; Female; Humans; Ketamine; Kynurenic Acid; Kynurenine; Male; Middle Aged; Psychiatric Status Rating Scales; Schizophrenia; Substance-Related Disorders; Tandem Mass Spectrometry; Time Factors; Tryptophan; Young Adult | 2020 |
[How can ketamine be used to manage suicidal risk?]
Topics: Anhedonia; Antidepressive Agents; Brain-Derived Neurotrophic Factor; Depressive Disorder, Major; Humans; Inflammation; Ketamine; Kynurenic Acid; Suicidal Ideation | 2023 |